Significance of prostate-specific antigen-α1-antichymotrypsin complex for diagnosis and staging of prostate cancer

Japanese Journal of Clinical Oncology

Volumn 31, Issue 10, 2001, Pages 506-509

  Hara, Isao ^a   Miyake, Hideaki ^a   Hara, Shoji ^a   Yamada, Yuji ^b   Takechi, Yoshizumi ^b   Fujisawa, Masato ^a   Okada, Hiroshi ^a   Arakawa, Soichi ^a   Kamidono, Sadao ^a  

^a KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HYOGO PREFECTURAL AWAJI HOSPITAL   (Japan)

Author keywords

Diagnosis; Prostate cancer; PSA; PSA ACT; Staging

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN;

AREA UNDER THE CURVE; ARTICLE; CALCULATION; CANCER STAGING; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DENSITY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; EVALUATION; FLUOROMETRY; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PROSTATE CANCER; PROSTATE DISEASE; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEIN DETERMINATION; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS;

ALPHA 1-ANTICHYMOTRYPSIN; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY;

EID: 0034758286     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Prostate specific antigen: A decade of discovery - What we have learned and where we are going
2. The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen
3. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease
4. Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies
5. 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: Assay of the complex improves clinical sensitivity for cancer
6. 1-antichymotrypsin in blood
7. Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer
8. 1-antichymotrypsin complex values in diagnosis cancer: A cooperative study
9. 1-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA
10. Comparison of two investigate assays for the complexed prostate-specific antigen in total prostate specific antigen between 4.1 and 10.0 ng/mL
11. Detection of prostate carcinoma using prostate specific antigen, its density and the density of the transition zone in Japanese men with intermediate serum prostate specific antigen concentrations
12. The meaning and use of the area under a receiver operating characteristic (ROC) curve